These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34900540)

  • 1. A smart O
    Zhang X; He C; Sun Y; Liu X; Chen Y; Chen C; Yan R; Fan T; Yang T; Lu Y; Luo J; Ma X; Xiang G
    Acta Pharm Sin B; 2021 Nov; 11(11):3608-3621. PubMed ID: 34900540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
    Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
    Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a hyaluronic acid-encapsulated tumor-targeted nanoplatform with sensitized chemotherapy and a photothermal effect for enhancing tumor therapy.
    Zhao WN; Xing J; Wang M; Li H; Sun S; Wang X; Xu Y
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130785. PubMed ID: 38471605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipase-Triggered Water-Responsive "Pandora's Box" for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug Penetration.
    Wang C; Chen S; Wang Y; Liu X; Hu F; Sun J; Yuan H
    Adv Mater; 2018 Apr; 30(14):e1706407. PubMed ID: 29484719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A solid lipid coated calcium peroxide nanocarrier enables combined cancer chemo/chemodynamic therapy with O
    He C; Zhang X; Chen C; Liu X; Chen Y; Yan R; Fan T; Gai Y; Lee RJ; Ma X; Luo J; Lu Y; Yang T; Xiang G
    Acta Biomater; 2021 Mar; 122():354-364. PubMed ID: 33359323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo.
    Cui T; Yan Z; Qin H; Sun Y; Ren J; Qu X
    Small; 2019 Oct; 15(42):e1903323. PubMed ID: 31468717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy.
    Yu J; Wang Y; Zhou S; Li J; Wang J; Chi D; Wang X; Lin G; He Z; Wang Y
    Acta Pharm Sin B; 2020 Sep; 10(9):1730-1740. PubMed ID: 33088692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
    Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
    J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
    Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
    Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress.
    Wang Z; Xu Y; Wu G; Zuo T; Zhang J; Yang J; Yang Y; Fang T; Shen Q
    ACS Biomater Sci Eng; 2021 Jan; 7(1):166-179. PubMed ID: 33372514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy.
    Chen M; Chen B; Ge X; Ma Q; Gao S
    Mol Pharm; 2023 May; 20(5):2389-2401. PubMed ID: 37042638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid/Hyaluronic Acid-Coated Doxorubicin-Fe
    Liang J; Yang X; Liu D; Cong M; Song Y; Bai S
    AAPS PharmSciTech; 2020 Aug; 21(6):235. PubMed ID: 32803528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
    Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
    Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
    Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
    Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment responsive hollow mesoporous Co
    Huang J; Huang Y; Xue Z; Zeng S
    Biomaterials; 2020 Dec; 262():120346. PubMed ID: 32927232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting.
    Xu L; Xu S; Wang H; Zhang J; Chen Z; Pan L; Wang J; Wei X; Xie H; Zhou L; Zheng S; Xu X
    ACS Appl Mater Interfaces; 2018 Jan; 10(4):3229-3240. PubMed ID: 29313660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.